Latest Breaking News On - Abstract code - Page 1 : comparemela.com

Affimed Announces Acceptance of an Abstract on Preclinical Data of its Innate Cell Engager AFM28 at the European Hematology Association 2024 Congress

Affimed Announces Acceptance of an Abstract on Preclinical Data of its Innate Cell Engager AFM28 at the European Hematology Association 2024 Congress
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesFrankfurt am mainBaden wübergWolfgang fischerArtiva alloMary beth sandinAlexander fudukidisIoanna tsoukalaEuropean hematology associationUniversity of texas md anderson cancer centerInstitute for tumor biologyAnnounces acceptancePreclinical dataInnate cell engagerHind medyoufTumor biology

Innovent and IASO Bio Present Updated Long-Term Follow-Up Data for BCMA CAR-T FUCASO® (Equecabtagene Autoleucel) at IMS 2023

/PRNewswire/ Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes.

Hong kongUnited statesLugui qiuEli lillyInnovent biologicsChunrui liEquecabtagene autoleucelAdimab incyteIncyte corporationPrnewswire innovent biologics incHuazhong university of science technologyTongji medical collegeInternational myeloma societyChina national medical products administrationMd anderson cancer centerChinese academy of medical science hematology hospital

Innovent and IASO Bio Present Updated Long-Term Follow-Up Data for BCMA CAR-T FUCASO® (Equecabtagene Autoleucel) at IMS 2023

Innovent and IASO Bio Present Updated Long-Term Follow-Up Data for BCMA CAR-T FUCASO® (Equecabtagene Autoleucel) at IMS 2023
sina.com.hk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sina.com.hk Daily Mail and Mail on Sunday newspapers.

United statesHong kongEli lillyAdimab incyteChunrui liLugui qiuEquecabtagene autoleucelIncyte corporationInnovent biologics incMd anderson cancer centerInternational myeloma societyTongji medical collegeChina national medical products administrationHuazhong university of science technologyChinese academy of medical science hematology hospitalComplete response

IASO Bio Presents Updated Long-Term Follow-Up Data for BCMA CAR-T FUCASO® (Equecabtagene Autoleucel) at IMS 2023

/PRNewswire/ IASO Bio, a biopharmaceutical company engaged in discovering, developing, manufacturing and marketing innovative cell therapies and antibody.

Lugui qiuAdimab incyteChunrui liEli lillyA equecabtagene autoleucelEquecabtagene autoleucelInnovent biologicsInnovent biologics incInternational myeloma societyHuazhong university of science technologyChinese academy of medical science hematology hospitalMd anderson cancer centerTongji medical collegeChina national medical products administrationComplete responseAbstract code

Innovent Announces Phase 1 Clinical Data of IBI322 (CD47/PD-L1 Bispecific Antibody) in the Treatment of Anti-PD-(L)1-resistant Classic Hodgkin Lymphoma Patients at the EHA 2023 Annual Meeting

/PRNewswire/ Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes.

United statesRhui zhouHong kongEli lillyInnovent biologicsAdimab incyteJingwei yuMeeting of the european society hematologyChina hospital of sichuan universityMd anderson cancer centerPrnewswire innovent biologics incTianjin medical university cancer institute hospitalIncyte corporationAnnual meetingEuropean societyAbstract code